Journals / Trakya University Journal of Natural Sciences / 2026 / Volume: 27 Issue: 2

Omentin-1 is associated with the expression of proliferation, migration, and PI3K/AKT-related gene in breast cancer cells

Ahu Soyocak(ISTANBUL AYDIN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES (MEDICINE), DEPARTMENT OF MEDICAL BIOLOGY)
Gülşah Koç(ISTANBUL AYDIN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES (MEDICINE), DEPARTMENT OF MEDICAL BIOLOGY)
Gonul Kanigur(ISTANBUL AYDIN UNIVERSITY, SCHOOL OF MEDICINE, DEPARTMENT OF BASIC MEDICAL SCIENCES (MEDICINE), DEPARTMENT OF MEDICAL EDUCATION)
Pages
—
Publication Date
2026-10-15
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Omentin-1 is associated with differential effects on BC cell behavior in a cell line-, dose-, and time-dependent manner, which are observed in parallel with alterations in the expression of PIK3CA/ AKT1- and cell migration-related genes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Breast cancer (BC) progression is regulated not only by intrinsic tumor characteristics but also by the tumor microenvironment, including adipose tissue-derived adipokines.
📊
Key Findings & Data:Omentin-1 (intelectin-1) is a visceral adipokine implicated in metabolic regulation and inflammation; however, its role in BC remains controversial and insufficiently defined.
💡
Conclusion & Impact:Conclusion: Omentin-1 is associated with differential effects on BC cell behavior in a cell line-, dose-, and time-dependent manner, which are observed in parallel with alterations in the expression of PIK3CA/ AKT1- and cell migration-related genes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Omentin-1 · breast cancer · PIK3CA

Abstract

Background: Breast cancer (BC) progression is regulated not only by intrinsic tumor characteristics but also by the tumor microenvironment, including adipose tissue-derived adipokines. Omentin-1 (intelectin-1) is a visceral adipokine implicated in metabolic regulation and inflammation; however, its role in BC remains controversial and insufficiently defined. Aims: This study aimed to evaluate the effects of omentin-1 on the proliferation, adhesion, and migration of BC cells and to investigate its association with the expression of PIK3CA/AKT1-related and migration-associated genes. Methods: MCF-7 (estrogen receptor-positive, weakly invasive) and MDA-MB-231 (estrogen receptor-negative, highly invasive) BC cell lines were treated with 100 and 200 ng/mL of recombinant omentin-1 for 24 and 48 h. Cell proliferation was assessed using the XTT assay, adhesion by an XTT-based method after washing, and migration via a wound-healing assay. The expression levels of PIK3CA, AKT1, and MMP-9 were analyzed by quantitative real-time polymerase chain reaction. Statistical significance was set at p < 0.05. Results: Omentin-1 significantly reduced proliferation in MCF-7 cells at 48 h by 20%–30% relative to control (p < 0.001), whereas no significant effect was observed in MDA-MB-231 cells (p > 0.05). Adhesion remained unchanged in the two cell lines (94%–100% across all groups, p > 0.05). Migration was significantly inhibited in MCF- 7 cells at 72 h, with gap closure declining from 85.71% to 62.98% and 58.98% (p = 0.031; p = 0.001). In contrast, MDA-MB-231 cells responded in a limited, time-dependent manner, with enhanced migration at 24 h and with no variations at 72 h due to complete closure. Gene expression analysis revealed dose- and time-dependent changes in transcription of PIK3CA, AKT1, and MMP-9, with each cell line showing distinct patterns. Conclusion: Omentin-1 is associated with differential effects on BC cell behavior in a cell line-, dose-, and time-dependent manner, which are observed in parallel with alterations in the expression of PIK3CA/ AKT1- and cell migration-related genes.

🔖

Cite This Article

Soyocak, A., Koç, G., Kanigur, G. (2026). Omentin-1 is associated with the expression of proliferation, migration, and PI3K/AKT-related gene in breast cancer cells. Trakya University Journal of Natural Sciences, Volume: 27 Issue: 2. https://doi.org/10.23902/trkjnat.202615

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (35)

  1. Abas, A.-S. M., Sherif, M. H., & Elmoneam Farag, S. A. (2022). Diagnostic and prognostic role of serum omentin and NGAL levels in Egyptian breast cancer patients. International Journal of Breast Cancer, 2022, Article 5971981. https:// doi.org/10.1155/2022/5971981
  2. Borowski, A., & Siemińska, L. (2020). Serum omentin levels in patients with prostate cancer and associations with sex steroids and metabolic syndrome. Journal of Clinical Medicine, 9(4), Article 1179. https://doi.org/10.3390/ jcm9041179
  3. Christodoulatos, G. S., Antonakos, G., Karampela, I., Psallida, S., Stratigou, T., Vallianou, N., Lekka, A., Marinou, I., Vogiatzakis, E., & Kokoris, S. (2021). Circulating omentin-1 as a biomarker at the intersection of postmenopausal breast cancer occurrence and cardiometabolic risk: An observational cross-sectional study. Biomolecules, 11(11), Article 1609. https://doi.org/10.3390/ biom11111609
  4. Dec, P., Poniewierska-Baran, A., Modrzejewski, A., & Pawlik, A. (2023). The role of omentin-1 in cancers development and progression. Cancers, 15(15), Article 3797. https://doi.org/10.3390/cancers15153797
  5. Dong, C., Wu, J., Chen, Y., Nie, J., & Chen, C. (2021). Activation of PI3K/ AKT/mTOR pathway causes drug resistance in breast cancer. Frontiers in Pharmacology, 12, Article 628690. https://doi.org/10.3389/fphar.2021.628690
  6. Ford, C. H. J., Al-Bader, M., Al-Ayadhi, B., & Francis, I. (2011). Reassessment of estrogen receptor expression in human breast cancer cell lines. Anticancer Research, 31(2), 521–527.
  7. Fruman, D. A., Chiu, H., Hopkins, B. D., Bagrodia, S., Cantley, L. C., & Abraham, R. T. (2017). The PI3K pathway in human disease. Cell, 170(4), 605–635. https:// doi.org/10.1016/j.cell.2017.07.029
  8. Gil, E. M. C. (2014). Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer. Cancer Treatment Reviews, 40(7), 862–871. https://doi.org/10.1016/j.ctrv.2014.03.004
  9. Glaviano, A., Foo, A. S. C., Lam, H. Y., Yap, K. C. H., Jacot, W., Jones, R. H., Eng, H., Nair, M. G., Makvandi, P., & Geoerger, B. (2023). PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. Molecular Cancer, 22(1), Article 138. https://doi.org/10.1186/s12943-023-01827-6
  10. Gu, N., Wang, J., Di, Z., Liu, Z., Jia, X., Yan, Y., Chen, X., Zhang, Q., & Qian, Y. (2019). The effects of intelectin-1 on antioxidant and angiogenesis in HUVECs exposed to oxygen glucose deprivation. Frontiers in Neurology, 10, Article 383. https://doi.org/10.3389/fneur.2019.00383
  11. Khatpe, A. S., Adebayo, A. K., Herodotou, C. A., Kumar, B., & Nakshatri, H. (2021). Nexus between PI3K/AKT and estrogen receptor signaling in breast cancer. Cancers, 13(3), Article 369. https://doi.org/10.3390/cancers13030369
  12. Khorasani, A. B. S., Hafezi, N., Sanaei, M., Jafari-Raddani, F., Pourbagheri- Sigaroodi, A., & Bashash, D. (2024). The PI3K/AKT/mTOR signaling pathway in breast cancer: Review of clinical trials and latest advances. Cell Biochemistry and Function, 42(3), Article e3998. https://doi.org/10.1002/cbf.3998
  13. Kothari, C., Diorio, C., & Durocher, F. (2020). The importance of breast adipose tissue in breast cancer. International Journal of Molecular Sciences, 21(16), Article 5760. https://doi.org/10.3390/ijms21165760
  14. Lamabadusuriya, D. A., Jayasena, H., Bopitiya, A. K., De Silva, A. D., & Mmpt, J. (2025). Obesity-driven inflammation and cancer risk: A comprehensive review. Seminars in Cancer Biology. Advance online publication. https://doi. org/10.1016/j.semcancer.2025.01.001
  15. Lee, Y.-R., Park, J., Yu, H.-N., Kim, J.-S., Youn, H. J., & Jung, S. H. (2005). Up-regulation of PI3K/Akt signaling by 17β-estradiol through activation of estrogen receptor-α, but not estrogen receptor-β, and stimulates cell growth in breast cancer cells. Biochemical and Biophysical Research Communications, 336(4), 1221– 1226. https://doi.org/10.1016/j.bbrc.2005.08.256 Li, D., Mei, H., Pu, J., Xiang, X., Zhao, X., Qu, H., Huang, K., Zheng, L., & Tong, Q. (2015a). Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2. Molecular Cancer, 14, Article 93. https://doi.org/10.1186/s12943-015-0320-6
  16. Li, D., Zhao, X., Xiao, Y., Mei, H., Pu, J., Xiang, X., Jiao, W., Song, H., Qu, H., & Huang, K. (2015b). Intelectin 1 suppresses tumor progression and is associated with improved survival in gastric cancer. Oncotarget, 6(18), 16168–16182. https://doi.org/10.18632/oncotarget.3753
  17. Llanos, A. A. M., Lin, Y., Chen, W., Yao, S., Norin, J., Chekmareva, M. A., Omene, C., Cong, L., Omilian, A. R., & Khoury, T. (2020). Immunohistochemical analysis of adipokine and adipokine receptor expression in the breast tumor microenvironment: Associations of lower leptin receptor expression with estrogen receptor-negative status and triple-negative subtype. Breast Cancer Research, 22(1), Article 18. https://doi.org/10.1186/s13058-020-1252-4
  18. Ma, X., Yang, S., & Li, D. (2025). New insights into adipokines and the tumor microenvironment in breast cancer. Cancer Control, 32, Article 10732748251347916. https://doi.org/10.1177/10732748251347916
  19. Maruyama, S., Shibata, R., Kikuchi, R., Izumiya, Y., Rokutanda, T., Araki, S., Kataoka, Y., Ohashi, K., Daida, H., & Kihara, S. (2012). Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase-dependent mechanism. Journal of Biological Chemistry, 287(1), 408–417. https://doi.org/10.1074/jbc.M111.261818
  20. Mohamood, A. S. (1995). Estrogen receptor, growth factor receptor and protooncogene protein activities and possible signal transduction crosstalk in estrogen dependent and independent breast cancer cell lines [Doctoral dissertation, Howard University].
  21. Mylonakis, A., Frountzas, M., Lidoriki, I., Kozadinos, A., Koloutsou, M. E., Margoni, A., Kalfoutzou, A., Theodorou, D., Toutouzas, K. G., & Schizas, D. (2025). The role of omentin in gastrointestinal cancer: Diagnostic, prognostic, and therapeutic perspectives. Metabolites, 15(10), Article 649. https://doi. org/10.3390/metabo15100649
  22. Naimo, G. D., Gelsomino, L., Catalano, S., Mauro, L., & Ando, S. (2020). Interfering role of ERα on adiponectin action in breast cancer. Frontiers in Endocrinology, 11, Article 66. https://doi.org/10.3389/fendo.2020.00066
  23. Ortega, M. A., Fraile-Martínez, O., Asúnsolo, Á., Buján, J., García-Honduvilla, N., & Coca, S. (2020). Signal transduction pathways in breast cancer: The important role of PI3K/Akt/mTOR. Journal of Oncology, 2020, Article 9258396. https://doi.org/10.1155/2020/9258396
  24. Panagiotou, G., Triantafyllidou, S., Tarlatzis, B. C., & Papakonstantinou, E. (2021). Serum levels of irisin and omentin-1 in breast neoplasms and their association with tumor histology. International Journal of Endocrinology, 2021, Article 5519607. https://doi.org/10.1155/2021/5519607
  25. Riggio, A. I., Varley, K. E., & Welm, A. L. (2021). The lingering mysteries of metastatic recurrence in breast cancer. British Journal of Cancer, 124(1), 13–26. https://doi.org/10.1038/s41416-020-01161-4
  26. Schmittgen, T. D., & Livak, K. J. (2008). Analyzing real-time PCR data by the comparative Ct method. Nature Protocols, 3(6), 1101–1108. https://doi. org/10.1038/nprot.2008.73
  27. Simoncini, T., Hafezi-Moghadam, A., Brazil, D. P., Ley, K., Chin, W. W., & Liao, J. K. (2000). Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature, 407(6803), 538–541. https://doi. org/10.1038/35035131
  28. Tahmasebpour, N., Feizi, M. A. H., Ziamajidi, N., Pouladi, N., Montazeri, V., Farhadian, M., & Abbasalipourkabir, R. (2020). Association of omentin-1 with oxidative stress and clinical significances in patients with breast cancer. Advanced Pharmaceutical Bulletin, 10(1), 106–113. https://doi.org/10.15171/apb.2020.013
  29. Verras, G.-I., Tchabashvili, L., Chlorogiannis, D.-D., Mulita, F., & Argentou, M.- I. (2023). Updated clinical evidence on the role of adipokines and breast cancer: A review. Cancers, 15(5), Article 1572. https://doi.org/10.3390/cancers15051572
  30. Yamawaki, H., Kuramoto, J., Kameshima, S., Usui, T., Okada, M., & Hara, Y. (2011). Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochemical and Biophysical Research Communications, 408(2), 339–343. https://doi.org/10.1016/j.bbrc.2011.04.039
  31. Ye, H., Luo, H., Tu, Y., & Cui, L. (2019). Omentin-1 promotes the proliferation, invasion, migration and angiogenesis of colorectal cancer cells. Journal of Biomaterials and Tissue Engineering, 9(5), 673–678. https://doi.org/10.1166/ jbt.2019.2056
  32. Zhang, H., Jiang, R., Zhu, J., Sun, K., Huang, Y., Zhou, H., Zheng, Y., & Wang, X. (2024). PI3K/AKT/mTOR signaling pathway: An important driver and therapeutic target in triple-negative breast cancer. Breast Cancer, 31(4), 539–551. https://doi.org/10.1007/s12282-024-01558-4
  33. Zhang, Y.-Y., & Zhou, L.-M. (2013). Omentin-1, a new adipokine, promotes apoptosis through regulating Sirt1-dependent p53 deacetylation in hepatocellular carcinoma cells. European Journal of Pharmacology, 698(1–3), 137–144. https:// doi.org/10.1016/j.ejphar.2012.11.016
  34. Zhang, Y., Zhao, X., & Chen, M. (2020). Autocrine action of adipokine omentin-1 in the SW480 colon cancer cell line. Oncology Letters, 19(1), 892–898. https:// doi.org/10.3892/ol.2019.11152
  35. Zheng, L., Weng, M., Qi, M., Qi, T., Tong, L., Hou, X., & Tong, Q. (2012). Aberrant expression of intelectin-1 in gastric cancer: Its relationship with clinicopathological features and prognosis. Journal of Cancer Research and Clinical Oncology, 138(1), 163–172. https://doi.org/10.1007/s00432-011-1084-y